{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:59:39Z","timestamp":1694631579035},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,2,10]],"date-time":"2008-02-10T00:00:00Z","timestamp":1202601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,2,10]],"date-time":"2008-02-10T00:00:00Z","timestamp":1202601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00105-008-1470-x","type":"journal-article","created":{"date-parts":[[2008,2,8]],"date-time":"2008-02-08T12:13:40Z","timestamp":1202472820000},"page":"200-205","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Insektengifthyposensibilisierung","Venom immunotherapy"],"prefix":"10.1007","volume":"59","author":[{"given":"F.","family":"Ru\u00ebff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Przybilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,10]]},"reference":[{"key":"1470_CR1","first-page":"B","volume":"91","author":"Arzneimittelkommision","year":"1994","unstructured":"Arzneimittelkommision der Deutschen \u00c4rzteschaft (1994) Anaphylaktoide Reaktionen bei Patienten mit ACE-Hemmer-Behandlung bei gleichzeitiger Desensibilisierungsbehandlung oder nach Insektenstichen. Arzneimittel-Schnellinformation des Bundesinstitutes f\u00fcr Arzneimittel und Medizinprodukte. Dtsch \u00c4rzteblatt 91: B-1762","journal-title":"Dtsch \u00c4rzteblatt"},{"key":"1470_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-2222.1993.tb00886.x","volume":"23","author":"Birnbaum","year":"1993","unstructured":"Birnbaum J, Charpin D, Vervloet D (1993) Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols. Clin Exp Allergy 23: 226\u2013230","journal-title":"Clin Exp Allergy"},{"key":"1470_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1046\/j.1365-2222.2003.01564.x","volume":"33","author":"Birnbaum","year":"2003","unstructured":"Birnbaum J, Ramadour M, Magnan A, Vervloet D (2003) Hymenoptera ultra-rush venom immunotherapy (210\u00a0min): a safety study and risk factors. Clin Exp Allergy 33: 58\u201364","journal-title":"Clin Exp Allergy"},{"key":"1470_CR4","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/j.1398-9995.2005.00960.x","volume":"60","author":"Bonifazi","year":"2005","unstructured":"Bonifazi F, Jutel M, Bil\u00f3 BM et al. (2005) Prevention and treatment of Hymenoptera venom allergy: guidelines for clinical practice. Allergy 60: 1459\u20131470","journal-title":"Allergy"},{"key":"1470_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","volume":"102","author":"Bousquet","year":"1998","unstructured":"Bousquet J, Lockey R, Malling HJ (1998) Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 102: 558\u2013562","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1067\/mai.2000.105708","volume":"105","author":"Brehler","year":"2000","unstructured":"Brehler R, Wolf H, Kutting B et al. (2000) Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol 105: 1231\u20131235","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0091-6749(97)70135-0","volume":"100","author":"Brockow","year":"1997","unstructured":"Brockow K, Kiehn M, Riethmuller C et al. (1997) Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 100: 458\u2013463","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR8","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/j.1398-9995.2004.00624.x","volume":"59","author":"Erdmann","year":"2004","unstructured":"Erdmann SM, Sachs B, Kwiecien R et al. (2004) The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy. Allergy 59: 1102\u20131109","journal-title":"Allergy"},{"key":"1470_CR9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1046\/j.1365-2222.2003.01644.x","volume":"33","author":"Gastaminza","year":"2003","unstructured":"Gastaminza G, Algorta J, Audicana M et al. (2003) Systemic reactions to immunotherapy: influence of composition and manufacturer. Clin Exp Allergy 33: 470\u2013474","journal-title":"Clin Exp Allergy"},{"key":"1470_CR10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1081-1206(10)61689-4","volume":"91","author":"Goldberg","year":"2003","unstructured":"Goldberg A, Confino-Cohen R (2003) Rush venom immunotherapy in patients experiencing recurrent systemic reactions to conventional venom immunotherapy. Ann Allergy Asthma Immunol 91: 405\u2013410","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1470_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/0091-6749(81)90082-8","volume":"67","author":"Golden","year":"1981","unstructured":"Golden DBK, Kagey-Sobotka A, Valentine MD, Lichtenstein LM (1981) Dose dependence of Hymenoptera venom immunotherapy. J Allergy Clin Immunol 67: 370\u2013374","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0091-6749(96)70302-0","volume":"97","author":"Golden","year":"1996","unstructured":"Golden DBK, Kwiterovich KA, Kagey-Sobotka A et al. (1996) Discontinuing venom immunotherapy: outcome after five years. J Allergy Clin Immunol 97: 579\u2013587","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR13","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1046\/j.1365-2222.2003.01755.x","volume":"33","author":"Haeberli","year":"2003","unstructured":"Haeberli G, Bronnimann M, Hunziker T, M\u00fcller U (2003) Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 33: 1216\u20131220","journal-title":"Clin Exp Allergy"},{"key":"1470_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0091-6749(91)90391-Z","volume":"87","author":"Haugaard","year":"1991","unstructured":"Haugaard L, N\u00f8rregaard OFH, Dahl R (1991) In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy. J Allergy Clin Immunol 87: 699\u2013702","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5414\/ALP24009","volume":"24","author":"Hipler","year":"2001","unstructured":"Hipler U-C, Bauer A, Schlenvoigt G, Elsner P (2001) Untersuchungen zur Verlaufskontrolle der Hyposensibilisierung mit Hilfe des Zellantigenstimulationstests (CAST). Allergologie 24: 9\u201313","journal-title":"Allergologie"},{"key":"1470_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJM197807272990401","volume":"299","author":"Hunt","year":"1978","unstructured":"Hunt KJ, Valentine MD, Sobotka AK et al. (1978) A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 299: 157\u2013161","journal-title":"N Engl J Med"},{"key":"1470_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0091-6749(91)90095-6","volume":"88","author":"Keating","year":"1991","unstructured":"Keating MU, Kagey-Sobotka A, Hamilton RG, Yunginger JW (1991) Clinical and immunologic follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol 88: 339\u2013348","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1398-9995.1997.tb02551.x","volume":"52","author":"Laurent","year":"1997","unstructured":"Laurent J, Smiejan JM, Bloch-Morot E, Herman D (1997) Safety of Hymenoptera venom rush immunotherapy. Allergy 52: 94\u201396","journal-title":"Allergy"},{"key":"1470_CR19","first-page":"482","volume":"14","author":"Lee","year":"2005","unstructured":"Lee H-H, Landeck L, Stefaniak R et al. (2005) Vertr\u00e4glichkeit der spezifischen Wespengift-Immuntherapie nach einem Rush- oder Ultra-Rush-Protokoll. Allergo J 14: 482\u2013486","journal-title":"Allergo J"},{"key":"1470_CR20","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1046\/j.1365-2222.2000.00910.x","volume":"30","author":"Mellerup","year":"2000","unstructured":"Mellerup MT, Hahn GW, Poulsen LK, Malling H (2000) Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy 30: 1423\u20131429","journal-title":"Clin Exp Allergy"},{"key":"1470_CR21","first-page":"1005","volume":"38","author":"Mokry","year":"1985","unstructured":"Mokry L, W\u00fcthrich B, Dietschi R (1985) Zur kausalen Behandlung der Hymenopterenstichallergie. Schweiz Rundschau Med 38: 1005\u20131016","journal-title":"Schweiz Rundschau Med"},{"key":"1470_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1398-9995.1986.tb00284.x","volume":"41","author":"Mosbech","year":"1986","unstructured":"Mosbech H, Malling H-J, Biering I et al. (1986) Immunotherapy with yellow jacket venom. Allergy 41: 95\u2013103","journal-title":"Allergy"},{"key":"1470_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1034\/j.1398-9995.2000.00587.x","volume":"55","author":"Mosbech","year":"2000","unstructured":"Mosbech H, M\u00fcller U (2000) Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology. Allergy 55: 1005\u20131010","journal-title":"Allergy"},{"key":"1470_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/0091-6749(91)90392-2","volume":"87","author":"M\u00fcller","year":"1991","unstructured":"M\u00fcller U, Berchtold E, Helbling A (1991) Honeybee venom allergy: results of a sting challenge 1\u00a0year after stopping successful venom immunotherapy in 86 patients. J Allergy Clin Immunol 87: 702\u2013709","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0091-6749(92)90319-W","volume":"89","author":"M\u00fcller","year":"1992","unstructured":"M\u00fcller U, Helbling A, Berchtold E (1992) Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 89: 529\u2013535","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR26","first-page":"99","volume":"58","author":"M\u00fcller","year":"2003","unstructured":"M\u00fcller UR (2003) Fatal course of Vespula venom immunotherapy: pretreatment withdrawal of the beta-blocker may have been involved. Allergy 58 (Suppl 74): 99\u2013100","journal-title":"Allergy"},{"key":"1470_CR27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaci.2004.11.012","volume":"115","author":"M\u00fcller","year":"2005","unstructured":"M\u00fcller UR, Haeberli G (2005) Use of beta-blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol 115: 606\u2013610","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR28","doi-asserted-by":"crossref","unstructured":"M\u00fcller UR (2008) Hautarzt, Hymenopterengift \u2013 Anaphylaxie und Herz-Kreislauf-Erkrankungen, Band 059. (Ver\u00f6ffentlichung in diesem Heft)","DOI":"10.1007\/s00105-008-1469-3"},{"key":"1470_CR29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0091-6749(97)70314-2","volume":"99","author":"Oude","year":"1997","unstructured":"Oude Elberink JNG, de Monchy JGR, Kors JW et al. (1997) Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis. J Allergy Clin Immunol 99: 153\u2013154","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR30","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-2008-1068068","volume":"112","author":"Przybilla","year":"1987","unstructured":"Przybilla B, Ring J, Grie\u00dfhammer B, Braun-Falco O (1987) Schnellhyposensibilisierung mit Hymenopterengiften. Vertr\u00e4glichkeit und Therapieerfolg. Dtsch Med Wochenschr 112: 416\u2013424","journal-title":"Dtsch Med Wochenschr"},{"key":"1470_CR31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF03361374","volume":"13","author":"Przybilla","year":"2004","unstructured":"Przybilla B, Ru\u00ebff F, Fuchs T et al. (2004) Insektengiftallergie. Leitlinie der Deutschen Gesellschaft f\u00fcr Allergologie und klinische Immunologie. Allergo J 13: 186\u2013190","journal-title":"Allergo J"},{"key":"1470_CR32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF03361374","volume":"13","author":"Przybilla","year":"2004","unstructured":"Przybilla B, M\u00fcller U, Jarisch R, Ru\u00ebff F (2004) Erh\u00f6hte basale Serumtryptasekonzentration oder Mastozytose als Risikofaktor der Hymenopterengiftallergie. Leitlinie der Deutschen Gesellschaft f\u00fcr Allergologie und klinische Immunologie. Allergo J 13: 440\u2013442","journal-title":"Allergo J"},{"key":"1470_CR33","first-page":"27","volume":"11","author":"Quercia","year":"2001","unstructured":"Quercia O, Rafanelli S, Puccinelli P, Stefanini GF (2001) The safety of cluster immunotherapy with aluminium hydroxide-adsorbed honey bee venom extract. J Investig Allergol Clin Immunol 11: 27\u201333","journal-title":"J Investig Allergol Clin Immunol"},{"key":"1470_CR34","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1034\/j.1398-9995.2000.00520.x","volume":"55","author":"Reimers","year":"2000","unstructured":"Reimers A, Hari Y, Muller U (2000) Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy 55: 484\u2013488","journal-title":"Allergy"},{"key":"1470_CR35","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1007\/BF03371938","volume":"16","author":"Rerinck","year":"2007","unstructured":"Rerinck HC, Przybilla B, Ru\u00ebff F (2007) Wiederholte anaphylaktische Reaktionen bei Bienengifthyposensibilisierung: Gute Vertr\u00e4glichkeit nach Omalizumabgabe. Allergo J 16: S95\u201396","journal-title":"Allergo J"},{"key":"1470_CR36","first-page":"79","volume":"16","author":"Roll","year":"2006","unstructured":"Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P (2006) Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy. J Investig Allergol Clin Immunol 16: 79\u201385","journal-title":"J Investig Allergol Clin Immunol"},{"key":"1470_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1081-1206(10)60626-6","volume":"99","author":"Roy","year":"2007","unstructured":"Roy SR, Sigmon JR, Olivier J et al. (2007) Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol 99: 82\u201386","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1470_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1398-9995.1996.tb00071.x","volume":"51","author":"Ru\u00ebff","year":"1996","unstructured":"Ru\u00ebff F, Przybilla B, M\u00fcller U, Mosbech H (1996) The sting challenge test in Hymenoptera venom allergy. Allergy 51: 216\u2013225","journal-title":"Allergy"},{"key":"1470_CR39","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1067\/mai.2001.119154","volume":"108","author":"Ru\u00ebff","year":"2001","unstructured":"Ru\u00ebff F, Wenderoth A, Przybilla B (2001) Patients still reacting to a sting challenge while receiving Hymenoptera venom immunotherapy are protected by increased venom doses. J Allergy Clin Immunol 108: 1027\u20131032","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR40","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1007\/BF03361102","volume":"12","author":"Ru\u00ebff","year":"2003","unstructured":"Ru\u00ebff F, Ludolph-Hauser D, Przybilla B (2003) Erh\u00f6hte basale Serumtryptrase als Risikofaktor der Insektengiftallergie. Allergo J 12: S32\u2013S38","journal-title":"Allergo J"},{"key":"1470_CR41","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1398-9995.2004.00505.x","volume":"59","author":"Ru\u00ebff","year":"2004","unstructured":"Ru\u00ebff F, Wolf H, Schnitker J et al. (2004) Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy 59: 589\u2013595","journal-title":"Allergy"},{"issue":"Suppl 1","key":"1470_CR42","first-page":"6","volume":"17","author":"F Ru\u00ebff","year":"2005","unstructured":"Ru\u00ebff F, Bauer C, Albert K, Przybilla B (2005) Mastocytosis is a stronger risk factor for treatment failure of Hymenoptera venom immunotherapy than elevated baseline serum tryptase. Allergy Clin Immunol Int \u2013 J WAO Org 17 (Suppl 1): 6","journal-title":"Allergy Clin Immunol Int \u2013 J WAO Org"},{"key":"1470_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1081-1206(10)61775-9","volume":"92","author":"Schiavino","year":"2004","unstructured":"Schiavino D, Nucera E, Pollastrini E et al. (2004) Specific ultrarush desensitization in Hymenoptera venom-allergic patients. Ann Allergy Asthma Immunol 92: 409\u2013413","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1470_CR44","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1398-9995.2007.01388.x","volume":"62","author":"Schulze","year":"2007","unstructured":"Schulze J, Rose M, Zielen S (2007) Beekeepers anaphylaxis: successful immunotherapy covered by omalizumab. Allergy 62: 963\u2013964","journal-title":"Allergy"},{"key":"1470_CR45","first-page":"148","volume":"27","author":"Steiss","year":"2006","unstructured":"Steiss JO, J\u00f6dicke B, Lindemann H (2006) A modified ultrarush insect venom immunotherapy protocol for children. Allergy Asthma Proc 27: 148\u201350","journal-title":"Allergy Asthma Proc"},{"key":"1470_CR46","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1067\/mai.2002.129124","volume":"110","author":"Sturm","year":"2002","unstructured":"Sturm G, Kranke B, Rudolph C, Aberer W (2002) Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients. J Allergy Clin Immunol 110: 928\u2013933","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR47","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0022-3476(85)80508-4","volume":"107","author":"Urbanek","year":"1985","unstructured":"Urbanek R, Forster J, Kuhn W, Ziupa J (1985) Discontinuation of bee venom immunotherapy in children and adolescents. J Pediatr 107: 367\u2013371","journal-title":"J Pediatr"},{"key":"1470_CR48","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0091-6749(97)70271-9","volume":"100","author":"Van","year":"1997","unstructured":"Van Halteren HK, van der Linden P-WG, Burgers JA, Bartelink AKM (1997) Discontinuation of yellow jacket venom immunotherapy: Follow-up of 75 patients by means of deliberate sting challenge. J Allergy Clin Immunol 100: 767\u2013770","journal-title":"J Allergy Clin Immunol"},{"key":"1470_CR49","first-page":"515","volume":"14","author":"Wieczorek","year":"2005","unstructured":"Wieczorek D, Kapp A, Wedi B (2005) Omalizumab erm\u00f6glicht Einleitung einer Hyposensibilisierungsbehandlung mit Bienengift bei Risikopatient mit erh\u00f6hter Serumtryptase. Allergo J 14: 515","journal-title":"Allergo J"},{"key":"1470_CR50","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1034\/j.1398-9995.2003.00268.x","volume":"58","author":"Wenzel","year":"2003","unstructured":"Wenzel J, Meissner-Kraemer M, Bauer R et al. (2003) Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients. Allergy 58: 1176\u20131179","journal-title":"Allergy"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1470-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-008-1470-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1470-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1470-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:04:17Z","timestamp":1652659457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-008-1470-x"}},"subtitle":["Nebenwirkungen und Therapieerfolg","Side effects and efficacy of treatment"],"short-title":[],"issued":{"date-parts":[[2008,2,10]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1007\/s00105-008-1470-x","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,10]]},"assertion":[{"value":"10 February 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}